Related Experiment Video
Updated: Oct 10, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Cardiac Remodeling and Repair: Recent Approaches, Advancements, and Future Perspective
Perwez Alam1, Bryan D Maliken2, Shannon M Jones1
1Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Adult heart cells (cardiomyocytes) do not regenerate well after injury, leading to heart failure. This review explores cell-based and cell-free therapies for cardiac repair, highlighting current progress and challenges.
Area of Science:
- Cardiovascular biology
- Regenerative medicine
- Cardiac pathology
Background:
- Limited proliferation of adult mammalian cardiomyocytes post-myocardial infarction causes adverse remodeling and heart failure.
- High morbidity and mortality associated with heart failure necessitate novel therapeutic strategies for cardiac repair.
Purpose of the Study:
- To review and discuss current cell-based and cell-free therapeutic approaches for cardiac repair.
- To highlight advancements, limitations, and future perspectives in myocardial regeneration.
Main Methods:
- Literature review of existing research on cardiac repair strategies.
- Analysis of cell-based and cell-free therapeutic interventions.
- Discussion of current advancements and challenges in the field.
Main Results:
- Various extrinsic strategies for myocardial regeneration show promise but lack clinical efficacy.
- Both cell-based and cell-free approaches are being investigated for cardiac repair.
- Significant limitations hinder the clinical translation of current therapeutic methods.
Conclusions:
- Developing effective therapeutics for cardiac repair remains a critical challenge.
- Further research is needed to overcome limitations in current cell-based and cell-free strategies.
- Future perspectives focus on enhancing the success of myocardial regeneration therapies.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

